Share Facebook Twitter LinkedIn Pinterest Email Stephen Sweetlove says he was reluctant to seek help because did not want to “burden the NHS”.
FibroBiologics advances bone marrow organoid platform for cancer and immune therapiesSeptember 12, 2025